$UTHR (UNITED THERAPEUTICS) — 8-K: United Therapeutics to repurchase ~$477.6M via ASR, completing $2.0B authorization

United Therapeutics will enter into an Accelerated Share Repurchase agreement with Citibank for approximately $477.6 million, using the remainder of its $2 billion share repurchase authorization. The company previously repurchased $1.5 billion via ASR agreements in March 2026 and bought $22.4 million in open-market transactions during the third quarter of 2026. Upon completion, United Therapeutics will have returned $4 billion to shareholders in approximately 2.5 years. As of September 4, 2026, the company had approximately 42.9 million shares outstanding.

United Therapeutics will enter into an Accelerated Share Repurchase agreement with Citibank for approximately $477.6 million, using the remainder of its $2 billion share repurchase authorization. The